Fang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fang Liu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Dongming He
7 shared publicationsGuannan Wang
Center for Advanced Biotechnology and Medicine, Rutgers, The State University of New Jersey, Piscataway, NJ, USA
7 shared publicationsIsao Matsuura
Center for Advanced Biotechnology and Medicine, Rutgers, The State University of New Jersey, Piscataway, NJ, USA
7 shared publicationsJianyin Long
Center for Advanced Biotechnology and Medicine, Rutgers, The State University of New Jersey, 679 Hoes Lane, Piscataway, NJ 08854, U.S.A.
5 shared publicationsNatalia G. Denissova
Center for Advanced Biotechnology and Medicine, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 679 Hoes Land, Piscataway, NJ 08854, USA
2 shared publicationsAkihide Ryo
1 shared publication
Latest Publications
- Open Access
- 30 August 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (40) , 64878-64885
Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice
Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice
- 30 August 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (40) , 64878-64885
Open AccessCarcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice
Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice
- 1 January 2016
- Published by Springer Nature
- Vol. 1344, 93-109
Phosphorylation of Smads by Intracellular Kinases
Smad proteins transduce the TGF-ß family signal at the cell surface into gene regulation in the nucleus. In addition to being phosphorylated by the TGF-ß family receptors, Smads are phosphorylated by a variety of intracellular kinases. The most studied are by cyclin-dependent kinases, the MAP kinase family members, and GSK-3. Phosphorylation by these kinases regulates Smad activities, leading to various biological effects. This chapter describes the methods for analyzing Smad phosphorylation by these kinases.
- 1 January 2016
- Published by Springer Nature
- Vol. 1344, 93-109
Phosphorylation of Smads by Intracellular Kinases
Smad proteins transduce the TGF-ß family signal at the cell surface into gene regulation in the nucleus. In addition to being phosphorylated by the TGF-ß family receptors, Smads are phosphorylated by a variety of intracellular kinases. The most studied are by cyclin-dependent kinases, the MAP kinase family members, and GSK-3. Phosphorylation by these kinases regulates Smad activities, leading to various biological effects. This chapter describes the methods for analyzing Smad phosphorylation by these kinases.
- Open Access
- 15 January 2011
- Published by Taylor & Francis in Cell Cycle
- Vol. 10 (2) , 191-190
Inhibition of Smad3 activity by cyclin D-CDK4 and cyclin E-CDK2 in breast cancer cells
Comment on: Cooley A, et al. Cell Cycle 2010; 9:4900–7.
- 15 January 2011
- Published by Taylor & Francis in Cell Cycle
- Vol. 10 (2) , 191-190
Open AccessInhibition of Smad3 activity by cyclin D-CDK4 and cyclin E-CDK2 in breast cancer cells
Comment on: Cooley A, et al. Cell Cycle 2010; 9:4900–7.
- Open Access
- 1 January 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (3) , 1754-1764
Pin1 Promotes Transforming Growth Factor-β-induced Migration and Invasion
- 1 January 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (3) , 1754-1764
Open AccessPin1 Promotes Transforming Growth Factor-β-induced Migration and Invasion
- Open Access
- 1 April 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (15) , 9663-9673
Transforming Growth Factor-β-inducible Phosphorylation of Smad3
- 1 April 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (15) , 9663-9673
Open AccessTransforming Growth Factor-β-inducible Phosphorylation of Smad3
- 18 November 2008
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 1 (46) , pe49
PCTA: A New Player in TGF-β Signaling
The distribution of promyelocytic leukemia protein between the nucleus and cytoplasm controls Smad activation.
- 18 November 2008
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 1 (46) , pe49
PCTA: A New Player in TGF-β Signaling
The distribution of promyelocytic leukemia protein between the nucleus and cytoplasm controls Smad activation.
- 29 December 2007
- Published by Springer Nature
- p. 185-206
Transcriptional Regulation by Smads
- 1 February 2006
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 17 (1-2) , 9-17
Smad3 phosphorylation by cyclin-dependent kinases
- 1 February 2006
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 17 (1-2) , 9-17
Smad3 phosphorylation by cyclin-dependent kinases
- 8 February 2005
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 386 (1) , 29-34
The Smad3 linker region contains a transcriptional activation domain
Transforming growth factor-beta (TGF-beta)/Smads regulate a wide variety of biological responses through transcriptional regulation of target genes. Smad3 plays a key role in TGF-beta/Smad-mediated transcriptional responses. Here, we show that the proline-rich linker region of Smad3 contains a transcriptional activation domain. When the linker region is fused to a heterologous DNA-binding domain, it activates transcription. We show that the linker region physically interacts with p300. The adenovirus E1a protein, which binds to p300, inhibits the transcriptional activity of the linker region, and overexpression of p300 can rescue the linker-mediated transcriptional activation. In contrast, an adenovirus E1a mutant, which cannot bind to p300, does not inhibit the linker-mediated transcription. The native Smad3 protein lacking the linker region is unable to mediate TGF-beta transcriptional activation responses, although it can be phosphorylated by the TGF-beta receptor at the C-terminal tail and has a significantly increased ability to form a heteromeric complex with Smad4. We show further that the linker region and the C-terminal domain of Smad3 synergize for transcriptional activation in the presence of TGF-beta. Thus our findings uncover an important function of the Smad3 linker region in Smad-mediated transcriptional control.
- 8 February 2005
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 386 (1) , 29-34
The Smad3 linker region contains a transcriptional activation domain
Transforming growth factor-beta (TGF-beta)/Smads regulate a wide variety of biological responses through transcriptional regulation of target genes. Smad3 plays a key role in TGF-beta/Smad-mediated transcriptional responses. Here, we show that the proline-rich linker region of Smad3 contains a transcriptional activation domain. When the linker region is fused to a heterologous DNA-binding domain, it activates transcription. We show that the linker region physically interacts with p300. The adenovirus E1a protein, which binds to p300, inhibits the transcriptional activity of the linker region, and overexpression of p300 can rescue the linker-mediated transcriptional activation. In contrast, an adenovirus E1a mutant, which cannot bind to p300, does not inhibit the linker-mediated transcription. The native Smad3 protein lacking the linker region is unable to mediate TGF-beta transcriptional activation responses, although it can be phosphorylated by the TGF-beta receptor at the C-terminal tail and has a significantly increased ability to form a heteromeric complex with Smad4. We show further that the linker region and the C-terminal domain of Smad3 synergize for transcriptional activation in the presence of TGF-beta. Thus our findings uncover an important function of the Smad3 linker region in Smad-mediated transcriptional control.
- 28 October 2004
- Published by Taylor & Francis in Cell Cycle
- Vol. 4 (1) , 63-66
Inhibition of Smad Antiproliferative Function by CDK Phosphorylation
Rb family members were the only demonstrated substrates of CDK4 until it was shown recently that Smad3, which plays a key role in mediating TGF-β antiproliferative responses, is phosphorylated by both CDK4 and CDK2 in vivo and in vitro. CDK phosphorylation of Smad3 inhibits its transcriptional activity and antiproliferative function. The Rb pathway is disrupted essentially in all types of human solid tumors. Most cancers contain high levels of CDK activity due to frequent inactivation of the p16 tumor suppressor or overexpression of cyclin D1. Therefore, disruption of the Rb pathway not only inactivates Rb, but also likely diminishes Smad activity, which may contribute to tumorigenesis and resistance to the TGF-β growth-inhibitory effects in cancers. Although genetic mutation of Smad3 has not been reported, CDK phosphorylation of Smad3 may provide an epigenetic mechanism for inhibition of the tumor suppressive function of Smad3 during the early stages of tumorigenesis.
- 28 October 2004
- Published by Taylor & Francis in Cell Cycle
- Vol. 4 (1) , 63-66
Inhibition of Smad Antiproliferative Function by CDK Phosphorylation
Rb family members were the only demonstrated substrates of CDK4 until it was shown recently that Smad3, which plays a key role in mediating TGF-β antiproliferative responses, is phosphorylated by both CDK4 and CDK2 in vivo and in vitro. CDK phosphorylation of Smad3 inhibits its transcriptional activity and antiproliferative function. The Rb pathway is disrupted essentially in all types of human solid tumors. Most cancers contain high levels of CDK activity due to frequent inactivation of the p16 tumor suppressor or overexpression of cyclin D1. Therefore, disruption of the Rb pathway not only inactivates Rb, but also likely diminishes Smad activity, which may contribute to tumorigenesis and resistance to the TGF-β growth-inhibitory effects in cancers. Although genetic mutation of Smad3 has not been reported, CDK phosphorylation of Smad3 may provide an epigenetic mechanism for inhibition of the tumor suppressive function of Smad3 during the early stages of tumorigenesis.